Janis Franklin
Family · Kennesaw, GANPI 1295344257
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,363 and has fallen 98.9% since, to $25 in 2025. Among family clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $23.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$728
- Amgen$649
- Biohaven Pharmaceuticals, Inc.$308
- Biogen$298
- UCB, Inc.$276
- Neurelis, Inc.$246
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,351100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $728 |
| Amgen(2 entities) | 25 | $649 |
| Biohaven Pharmaceuticals, Inc. | 11 | $308 |
| Biogen | 15 | $298 |
| UCB, Inc. | 11 | $276 |
| Neurelis, Inc. | 7 | $246 |
| Lundbeck LLC | 10 | $203 |
| Kyowa Kirin, Inc. | 6 | $188 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $171 |
| Neurocrine Biosciences, Inc. | 6 | $153 |
| Teva Pharmaceuticals USA, Inc. | 7 | $138 |
| Avion Pharmaceuticals | 5 | $94 |
| Sanofi | 1 | $88 |
| AstraZeneca(2 entities) | 5 | $84 |
| Aquestive Therapeutics, Inc. | 4 | $82 |
| Impel Pharmaceuticals Inc. | 4 | $79 |
| Supernus Pharmaceuticals, Inc. | 4 | $77 |
| Ipsen Biopharmaceuticals, Inc | 3 | $69 |
| Eisai Inc. | 3 | $67 |
| Sunovion Pharmaceuticals Inc. | 3 | $58 |
| Amneal Pharmaceuticals LLC | 3 | $58 |
| Adamas Pharmaceuticals, Inc. | 3 | $56 |
| Acorda Therapeutics, Inc | 2 | $30 |
| CSL Behring | 1 | $26 |
| Johnson & Johnson | 1 | $24 |
| Pfizer | 1 | $23 |
| Novartis | 1 | $21 |
| Merck | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$124
- UPLIZNA$123
- AIMOVIG$121
- NURTEC ODT$113
- VALTOCO$105
How this compares
$4,351 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Other family in Kennesaw
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.